Royal Bank of Canada’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1K Sell
313
-2,559
-89% -$10.2K ﹤0.01% 6933
2025
Q4
$11K Sell
2,872
-277,837
-99% -$951K ﹤0.01% 6374
2025
Q3
$915K Sell
280,709
-97,087
-26% -$306K ﹤0.01% 4058
2025
Q2
$925K Buy
377,796
+361,940
+2,283% +$1.83M ﹤0.01% 3962
2025
Q1
$106K Buy
15,856
+7,244
+84% +$71.6K ﹤0.01% 5178
2024
Q4
$108K Sell
8,612
-5,132
-37% -$77.3K ﹤0.01% 5296
2024
Q3
$254K Buy
13,744
+4,515
+49% +$92.5K ﹤0.01% 4622
2024
Q2
$198K Buy
9,229
+5,021
+119% +$115K ﹤0.01% 4781
2024
Q1
$113K Sell
4,208
-16,431
-80% -$467K ﹤0.01% 5120
2023
Q4
$619K Buy
20,639
+9,826
+91% +$217K ﹤0.01% 4075
2023
Q3
$222K Buy
10,813
+3,579
+49% +$65.1K ﹤0.01% 4698
2023
Q2
$144K Sell
7,234
-15,631
-68% -$316K ﹤0.01% 5038
2023
Q1
$392K Buy
22,865
+12,482
+120% +$244K ﹤0.01% 4069
2022
Q4
$203K Buy
10,383
+9,850
+1,848% +$181K ﹤0.01% 4870
2022
Q3
$9K Sell
533
-18,296
-97% -$285K ﹤0.01% 6482
2022
Q2
$259K Buy
18,829
+16,296
+643% +$194K ﹤0.01% 4595
2022
Q1
$40K Sell
2,533
-6,408
-72% -$111K ﹤0.01% 6240
2021
Q4
$195K Buy
8,941
+5,532
+162% +$151K ﹤0.01% 5362
2021
Q3
$102K Buy
3,409
+689
+25% +$25.1K ﹤0.01% 5681
2021
Q2
$120K Sell
2,720
-33,166
-92% -$1.44M ﹤0.01% 5486
2021
Q1
$1.59M Buy
35,886
+35,750
+26,287% +$1.96M ﹤0.01% 3202
2020
Q4
$8K Buy
+136
New +$4.96K ﹤0.01% 6487
2020
Q2
Sell
-150
Closed -$2K 6859
2020
Q1
$2K Sell
150
-974
-87% -$19.3K ﹤0.01% 6322
2019
Q4
$26K Buy
+1,124
New +$18.8K ﹤0.01% 5746
2018
Q4
Sell
-635
Closed -$16K 7046
2018
Q3
$16K Sell
635
-1,106
-64% -$24K ﹤0.01% 5785
2018
Q2
$34K Sell
1,741
-653
-27% -$12.4K ﹤0.01% 5318
2018
Q1
$45K Buy
+2,394
New +$39K ﹤0.01% 5102
2017
Q4
Sell
-5
Closed 6816
2017
Q3
$0 Buy
+5
New +$23 ﹤0.01% 6931
2017
Q2
Sell
-659
Closed -$5K 6726
2017
Q1
$5K Buy
659
+22
+3% +$148 ﹤0.01% 6219
2016
Q4
$15K Buy
637
+382
+150% +$10.9K ﹤0.01% 5918
2016
Q3
$9K Buy
+255
New +$8.02K ﹤0.01% 5819

Other funds holding RCKT